These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36512463)

  • 1. Editorial Comment: Secondary polycythemia in men receiving testosterone therapy increases risk of major adverse cardiovascular events and venous thromboembolism in the first year of therapy.
    Barros R
    Int Braz J Urol; 2023; 49(1):150-151. PubMed ID: 36512463
    [No Abstract]   [Full Text] [Related]  

  • 2. Secondary Polycythemia in Men Receiving Testosterone Therapy Increases Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism in the First Year of Therapy. Letter.
    Kaplan-Marans E
    J Urol; 2022 Sep; 208(3):566-567. PubMed ID: 35648648
    [No Abstract]   [Full Text] [Related]  

  • 3. Secondary Polycythemia in Men Receiving Testosterone Therapy Increases Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism in the First Year of Therapy. Reply.
    Ory J; Ramasamy R
    J Urol; 2022 Sep; 208(3):567. PubMed ID: 35648647
    [No Abstract]   [Full Text] [Related]  

  • 4. Secondary Polycythemia in Men Receiving Testosterone Therapy Increases Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism in the First Year of Therapy.
    Ory J; Nackeeran S; Balaji NC; Hare JM; Ramasamy AR
    J Urol; 2022 Jun; 207(6):1295-1301. PubMed ID: 35050717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparison of Secondary Polycythemia in Hypogonadal Men Treated with Clomiphene Citrate versus Testosterone Replacement: A Multi-Institutional Study.
    Wheeler KM; Smith RP; Kumar RA; Setia S; Costabile RA; Kavoussi PK
    J Urol; 2017 Apr; 197(4):1127-1131. PubMed ID: 27984109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone replacement therapy and polycythemia in HIV-infected patients.
    Vorkas CK; Vaamonde CM; Glesby MJ
    AIDS; 2012 Jan; 26(2):243-5. PubMed ID: 22008652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Abdominal pain and hypertension in a 55-year-old male patient].
    Kofler T; Yueksel F; Dirnhofer S; Donath MY; Trendelenburg M
    Internist (Berl); 2017 Apr; 58(4):397-401. PubMed ID: 28005140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocytosis Following Testosterone Therapy.
    Ohlander SJ; Varghese B; Pastuszak AW
    Sex Med Rev; 2018 Jan; 6(1):77-85. PubMed ID: 28526632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks of testosterone-replacement therapy and recommendations for monitoring.
    Rhoden EL; Morgentaler A
    N Engl J Med; 2004 Jan; 350(5):482-92. PubMed ID: 14749457
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of subcutaneous testosterone pellet therapy with developing secondary polycythemia.
    Rotker KL; Alavian M; Nelson B; Baird GL; Miner MM; Sigman M; Hwang K
    Asian J Androl; 2018; 20(2):195-199. PubMed ID: 29205178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Erythrocytosis During Concomitant Testosterone and SGLT2-Inhibitor Treatment: A Warning From Two Clinical Cases.
    Motta G; Zavattaro M; Romeo F; Lanfranco F; Broglio F
    J Clin Endocrinol Metab; 2019 Mar; 104(3):819-822. PubMed ID: 30395251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of polycythaemia induced by intramuscular androgen replacement using transdermal testosterone therapy.
    Siddique H; Smith JC; Corrall RJ
    Clin Endocrinol (Oxf); 2004 Jan; 60(1):143-5. PubMed ID: 14678301
    [No Abstract]   [Full Text] [Related]  

  • 13. [Andrological testosterone replacement therapy].
    Paasch U; Glander HJ; Stolzenburg JU
    Urologe A; 2009 Jan; 48(1):79-86; quiz 87. PubMed ID: 19156339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone deficiency syndrome: benefits, risks, and realities associated with testosterone replacement therapy.
    Hassan J; Barkin J
    Can J Urol; 2016 Feb; 23(Suppl 1):20-30. PubMed ID: 26924592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone replacement therapy and cardiovascular events.
    Çatakoğlu AB; Kendirci M
    Turk Kardiyol Dern Ars; 2017 Oct; 45(7):664-672. PubMed ID: 28990951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks of testosterone replacement therapy in ageing men.
    Tan RS; Salazar JA
    Expert Opin Drug Saf; 2004 Nov; 3(6):599-606. PubMed ID: 15500418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polycythemia in a physician secondary to self-administered growth hormone, testosterone, and dehydroepiandrosterone to prevent aging.
    Kwong YL; Lam CC
    J Am Geriatr Soc; 2004 Jun; 52(6):1031-2. PubMed ID: 15161484
    [No Abstract]   [Full Text] [Related]  

  • 18. Hormone Replacement Therapy in a Patient with Hypogonadism and Coexisting Medical Conditions.
    Dural Ö; Poyrazoğlu Ş
    J Clin Res Pediatr Endocrinol; 2020 Feb; 12(Suppl 1):46-49. PubMed ID: 32041392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstructive Sleep Apnea Is Associated With Polycythemia in Hypogonadal Men on Testosterone Replacement Therapy.
    Lundy SD; Parekh NV; Shoskes DA
    J Sex Med; 2020 Jul; 17(7):1297-1303. PubMed ID: 32307242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing Rates of Polycythemia in Hypogonadal Men Using Nasal Testosterone Gel Versus Intramuscular Testosterone: Update of a Randomized Clinical Trial.
    Ory J; Diaz P; Rivero MJ; Clavijo RI; Thirumavalavan N; Blachman-Braun R; Loloi J; Bernstein A; Ramasamy R
    Eur Urol Focus; 2023 Jan; 9(1):14-16. PubMed ID: 36109330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.